Benzinga

Benzinga

Benzinga

viernes, agosto 28

Alignment Healthcare Inc

ALHCNASDAQ
Trade with Public
Trade with Public
$13.77
0.211.55%
Últ. Act.: Aug 28, 1:32 PM
Panorámica generalNoticiasPrevisión de beneficiosEventosPrecios objetivoFinanzasSentimientoPropiedadCompararOpcionesInforme de acciones

Alignment Healthcare Analyst Price Targets

Wall Street analyst price targets and consensus rating for Alignment Healthcare (ALHC).

Price Target Range — 13 Quarters

Analyst Consensus — 12 Analysts

11Buy
1Hold
Consensus RatingOverweight# Analysts12Avg. Consensus PT$19Upside to Avg. PT+41.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 4, 2026JP MorganJohn StanselPT CutOverweight$26→$22
Aug 3, 2026Raymond JamesJohn RansomDowngradeStrong Buy→Outperform$22→$19
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
JP Morgan Maintains Overweight on Alignment Healthcare, Lowers Price Target to $22

JP Morgan analyst John Stansel maintains Alignment Healthcare (NASDAQ:ALHC) with a Overweight and lowers the price target from $26 to $22.
Benzinga Newsdesk

PRO
Raymond James Downgrades Alignment Healthcare to Outperform, Lowers Price Target to $19

Raymond James analyst John Ransom downgrades Alignment Healthcare (NASDAQ:ALHC) from Strong Buy to Outperform and lowers the price target from $22 to $19.
Benzinga Newsdesk

PRO
UBS Maintains Neutral on Alignment Healthcare, Raises Price Target to $22

UBS analyst Jonathan Yong maintains Alignment Healthcare (NASDAQ:ALHC) with a Neutral and raises the price target from $21 to $22.
Benzinga Newsdesk

PRO
Barclays Maintains Equal-Weight on Alignment Healthcare, Raises Price Target to $19

Barclays analyst Andrew Mok maintains Alignment Healthcare (NASDAQ:ALHC) with a Equal-Weight and raises the price target from $18 to $19.
Benzinga Newsdesk

6 Analysts Have This To Say About Alignment Healthcare

Benzinga Insights

PRO
JP Morgan Maintains Overweight on Alignment Healthcare, Raises Price Target to $26

JP Morgan analyst John Stansel maintains Alignment Healthcare (NASDAQ:ALHC) with a Overweight and raises the price target from $23 to $26.
Benzinga Newsdesk

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Datos de mercado proporcionados por APIs de Benzinga

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved